147 related articles for article (PubMed ID: 38059681)
1. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract][Full Text] [Related]
2. Predictors of adherence to Narrowband ultraviolet B first-month treatment dosage plan.
Pavlotsky F; Alkhazov A; Barzilai A; Scope A
Isr Med Assoc J; 2022 Dec; 25(12):820-823. PubMed ID: 36573776
[TBL] [Abstract][Full Text] [Related]
3. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
4. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of narrowband UVB phototherapy in early-stage mycosis fungoides in Iranian patients.
Shirzadian Kebria A; Asghari J; Tirgar Tabari S; Aryanian Z; Shirafkan H
Lasers Med Sci; 2022 Oct; 37(8):3231-3235. PubMed ID: 35838846
[TBL] [Abstract][Full Text] [Related]
6. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
7. Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study.
Zengarini C; Baruffaldi G; Piraccini BM; Bardazzi F; Mussi M; Hrvatin Stancic B; Pileri A
Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):435-440. PubMed ID: 36974002
[TBL] [Abstract][Full Text] [Related]
8. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
Pattamadilok B; Poomputsar T
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
[TBL] [Abstract][Full Text] [Related]
9. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases.
Myers E; Kheradmand S; Miller R
Cureus; 2021 Nov; 13(11):e19182. PubMed ID: 34873522
[TBL] [Abstract][Full Text] [Related]
10. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
11. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
13. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
Sonthalia S
J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Biological Effects and Transcriptome Changes Induced by LED-Based Narrow-Band UVB Phototherapy.
Liu X; Chen H; Li Z; Duan L; Yang X; Jiang P; Xu L; Gong Y; Han K
Photochem Photobiol; 2022 Nov; 98(6):1379-1389. PubMed ID: 35538716
[TBL] [Abstract][Full Text] [Related]
15. The impact of therapeutic modalities on patients with atopic dermatitis, psoriasis and vitiligo treated with phototherapy in the Jagiellonian University Outpatient Clinic.
Englert K; Kłosowicz A; Pelc P; Pastuszczak M; Wojas-Pelc A
Pol Merkur Lekarski; 2019 Mar; 46(273):125-129. PubMed ID: 30912521
[TBL] [Abstract][Full Text] [Related]
16. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
18. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
19. Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides.
Pavlotsky F; Dawood M; Barzilai A
J Am Acad Dermatol; 2019 Jun; 80(6):1550-1555. PubMed ID: 29800582
[TBL] [Abstract][Full Text] [Related]
20. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]